Search clinical trials for: Myocet / Paclitaxel
Total 4062 results
-
Fujian Cancer HospitalNot yet recruitingAdvanced Solid Tumor
-
Tang-Du HospitalRecruitingThymoma and Thymic CarcinomaChina
-
All India Institute of Medical Sciences, New DelhiUnknownMetastatic Carcinoma to the Uterine Cervix | Recurrent Carcinoma Cervix | Cervix Carcinoma RecurrentIndia
-
Guangdong Association of Clinical TrialsNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...Sun Yat-sen University; Peking University International Hospital; Zhejiang UniversityNot yet recruitingHER2-positive Breast Cancer | Brain MetastasesChina
-
Henan Cancer HospitalUnknown
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
University of RochesterCelgene CorporationWithdrawnNon-small Cell Lung Cancer, Stage IIIUnited States
-
Nanfang Hospital of Southern Medical UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.RecruitingChemotherapy | ImmunotherapyChina
-
Sun Yat-sen UniversityUnknownNasopharyngeal Cancer | Non Small Cell Lung Cancer | Liver MetastasisChina
-
Health Science Center of Xi'an Jiaotong UniversityCompletedSquamous Carcinoma of Esophagus | Esophagus DisordersChina
-
Spanish Cooperative Group for the Treatment of...CompletedMetastatic Pancreatic AdenocarcinomaSpain
-
Fudan UniversityUnknown
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
Tang-Du HospitalRecruitingLocally Advanced Cervical CancerChina
-
Fudan UniversityRecruitingLaryngeal Cancer | Laryngeal Neoplasms | Hypopharynx CancerChina
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
Cancer Institute and Hospital, Chinese Academy...RecruitingChemotherapy Effect | Locally Advanced Breast CancerChina
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
National Cancer Center, KoreaKorean Cancer Study GroupRecruiting
-
Emory UniversityNational Cancer Institute (NCI); Lexicon PharmaceuticalsActive, not recruitingStage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic Adenocarcinoma | Recurrent Pancreatic AdenocarcinomaUnited States
-
Hospices Civils de LyonCompletedOvarian CancerDenmark, Sweden, Finland, Italy, Canada, France
-
Hebei Medical University Fourth HospitalBeijing 302 Hospital; CSPC Ouyi Pharmaceutical Co., Ltd.UnknownBreast Cancer | Triple-negative Breast Cancer | Nab-paclitaxelChina
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedNeoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast CancerBreast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Centre Leon BerardCompletedFRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel (FRAIL-IMMUNE)Squamous Cell Carcinoma of the Head and NeckFrance
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Not yet recruitingTriple Negative Breast CancerChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingCholangiocarcinoma
-
University of Colorado, DenverCancer League of ColoradoWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | PD-L1 Gene MutationUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Breast Adenocarcinoma | Inflammatory Breast CarcinomaUnited States
-
National Cancer Institute (NCI)SuspendedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
Fulgent Pharma LLC.RecruitingHead and Neck Squamous Cell CarcinomaUnited States
-
Tongji HospitalUnknown
-
Guo XufengRecruitingEsophageal Squamous Cell Carcinoma | Adjuvant Therapy | Neoadjuvant ChemoimmunotherapyChina
-
CTI BioPharmaWithdrawn
-
University of MiamiCompletedPancreatic CancerUnited States, Singapore
-
The Methodist Hospital Research InstituteCellular TherapeuticsCompleted
-
Celgene CorporationTerminated
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingAdvanced Gastric Adenocarcinoma and Esophageal Squamous Cell CarcinomaChina
-
Sun Yat-sen UniversityShanghai Junshi Bioscience Co., Ltd.; CSPC Ouyi Pharmaceutical Co., Ltd.RecruitingEsophageal Small Cell CarcinomaChina
-
Helse Stavanger HFUnknownMetastatic Pancreatic CancerNorway
-
Fujian Medical University Union HospitalNot yet recruitingChemotherapy | Radiation TherapyChina
-
First People's Hospital of FoshanNot yet recruiting
-
Boston Scientific CorporationCompletedAtherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial DiseaseUnited States, Belgium, Canada, Japan, Austria, New Zealand
-
BeiGeneCompletedA Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung CancerNon-Small Cell Lung CancerChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMetastatic Urothelial CarcinomaItaly
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation; National Comprehensive Cancer NetworkCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)UnknownLung CancerUnited States